Bharat Biotech to advance development of GSK's Shigella vaccine
'iNCOVACC, testimony to innovative zeal of our scientists'
Mandaviya unveiled the Inncovacc- the first India-made nasal Covid-19 vaccine today in the presence of Union...
iNCOVACC world's first intra-nasal vaccine to receive approval
Nigeria introduces Bharat Biotech's Rotavac vaccine for children
Covaxin safe for children aged 2-18 years, says Bharat Biotech
Indian Immunologicals hands over first lot of Covaxin drug...
COVAXIN shows 81 pc efficiency in phase three trials, says ICMR
New Delhi [India], March 3 (ANI): Phase three results of the COVAXIN, a vaccine against COVID-19 which has been...
'A powerful example for all Indians': Bharat Biotech after PM...
Bharat Biotech confirms deal with Brazil to supply 20 million...
New Delhi [India], February 26 (ANI): Bharat Biotech International Limited on Friday confirmed that the company...
Bharat Biotech dispatches COVID-19 vaccine Covaxin to 11...
Hyderabad (Telangana) [India], January 13 (ANI): The Bharat Biotech International Limited (BBIL) has announced...
Bharat Biotech seeks DCGI's nod to conduct trials of nasal...
New Delhi [India], January 8 (ANI): The Bharat Biotech International Limited has sent a proposal to the Drugs...
COVID-19: Bharat Biotech enrols 25,800 volunteers for Covaxin...
Hyderabad (Telangana) [India], January 7 (ANI): The Bharat Biotech International Limited on Thursday announced...
Copyright © aninews.in | All Rights Reserved.